EFIN saw its Momentum Indicator move above the 0 level on December 10, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 73 similar instances where the indicator turned positive. In of the 73 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Aroon Indicator entered an Uptrend today. In of 248 cases where EFIN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for EFIN moved out of overbought territory on November 13, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where EFIN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for EFIN turned negative on November 13, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .
EFIN broke above its upper Bollinger Band on November 12, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: EFIN's P/B Ratio (0.000) is slightly lower than the industry average of (1.030). P/E Ratio (0.000) is within average values for comparable stocks, (18.662). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.366). Dividend Yield (0.058) settles around the average of (0.058) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (2.921).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EFIN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry RegionalBanks
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 55.78 | 0.38 | +0.69% |
ProShares Ultra Nasdaq Biotechnology | |||
SCHH | 21.75 | -0.07 | -0.32% |
Schwab US REIT ETF™ | |||
QRFT | 54.76 | -0.21 | -0.39% |
QRAFT AI-Enhanced US Large Cap ETF | |||
DFEV | 26.76 | -0.11 | -0.40% |
Dimensional Emerging Markets Value ETF | |||
XMPT | 21.95 | -0.20 | -0.90% |
VanEck CEF Municipal Income ETF |
A.I.dvisor tells us that EFIN and QCCO have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EFIN and QCCO's prices will move in lockstep.
Ticker / NAME | Correlation To EFIN | 1D Price Change % | ||
---|---|---|---|---|
EFIN | 100% | N/A | ||
QCCO - EFIN | 26% Poorly correlated | -33.98% | ||
JPPHY - EFIN | 21% Poorly correlated | N/A | ||
DNBBF - EFIN | 8% Poorly correlated | -0.11% | ||
DNKEY - EFIN | 6% Poorly correlated | -2.26% | ||
DWNX - EFIN | 5% Poorly correlated | N/A | ||
More |